Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 141

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Type 2 Diabetes and Congenital Hyperinsulinism Cause DNA Double-Strand Breaks and p53 Activity in β Cells

Tornovsky-Babeay, Sharona, Dadon, Daniela, Ziv, Oren, Tzipilevich, Elhanan, Kadosh, Tehila, Schyr-Ben Haroush, Rachel, Hija, Ayat, Stolovich-Rain, Miri, Furth-Lavi, Judith, Granot, Zvi, Porat, Shay, Philipson, Louis H., Herold, Kevan C., Bhatti, Tricia R., Stanley, Charles, Ashcroft, Frances M., In’t Veld, Peter, Saada, Ann, Magnuson, Mark A., Glaser, Benjamin, Dor, Yuval·2014·Cell Metabolism
DOI 10.1016/j.cmet.2013.11.007
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2013.11.007

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 50

  1. Beltrand, 2012, Glucose metabolism in 105 children and adolescents after pancreatectomy for congenital hyperinsulinism, Diabetes Care, 35, 198, 10.2337/dc11-1296 · DOI
  2. Bensellam, 2012, The molecular mechanisms of pancreatic β-cell glucotoxicity: recent findings and future research directions, Mol. Cell. Endocrinol., 364, 1, 10.1016/j.mce.2012.08.003 · DOI · Paper page
  3. Butler, 2003, Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes, Diabetes, 52, 102, 10.2337/diabetes.52.1.102 · DOI · Paper page
  4. Cuesta-Muñoz, 2004, Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation, Diabetes, 53, 2164, 10.2337/diabetes.53.8.2164 · DOI · Paper page
  5. de Vathaire, 2012, Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study, Lancet Oncol., 13, 1002, 10.1016/S1470-2045(12)70323-6 · DOI · Paper page
  6. Doliba, 2012, Glucokinase activation repairs defective bioenergetics of islets of Langerhans isolated from type 2 diabetics, Am. J. Physiol. Endocrinol. Metab., 302, E87, 10.1152/ajpendo.00218.2011 · DOI · Paper page
  7. Eizirik, 2008, The role for endoplasmic reticulum stress in diabetes mellitus, Endocr. Rev., 29, 42, 10.1210/er.2007-0015 · DOI · Paper page
  8. Gannon, 2000, Analysis of the Cre-mediated recombination driven by rat insulin promoter in embryonic and adult mouse pancreas, Genesis, 26, 139, 10.1002/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7 · DOI · Paper page
  9. Glaser, 1998, Familial hyperinsulinism caused by an activating glucokinase mutation, N. Engl. J. Med., 338, 226, 10.1056/NEJM199801223380404 · DOI · Paper page
  10. Glaser, 1999, Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea-receptor gene, Diabetes, 48, 1652, 10.2337/diabetes.48.8.1652 · DOI
  11. Greig, 2004, New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists, Ann. N Y Acad. Sci., 1035, 290, 10.1196/annals.1332.018 · DOI
  12. Gu, 2002, Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors, Development, 129, 2447, 10.1242/dev.129.10.2447 · DOI · Paper page
  13. Halazonetis, 2008, An oncogene-induced DNA damage model for cancer development, Science, 319, 1352, 10.1126/science.1140735 · DOI · Paper page
  14. Hinault, 2011, Δ40 Isoform of p53 controls β-cell proliferation and glucose homeostasis in mice, Diabetes, 60, 1210, 10.2337/db09-1379 · DOI
  15. Huopio, 2003, A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1, Lancet, 361, 301, 10.1016/S0140-6736(03)12325-2 · DOI · Paper page
  16. James, 2009, The genetic basis of congenital hyperinsulinism, J. Med. Genet., 46, 289, 10.1136/jmg.2008.064337 · DOI
  17. Kaneto, 2008, PDX-1 and MafA play a crucial role in pancreatic beta-cell differentiation and maintenance of mature beta-cell function, Endocr. J., 55, 235, 10.1507/endocrj.K07E-041 · DOI · Paper page
  18. Karunakaran, 2012, Guards and culprits in the endoplasmic reticulum: glucolipotoxicity and β-cell failure in type II diabetes, Exp. Diabetes Res., 2012, 639762, 10.1155/2012/639762 · DOI
  19. Kassem, 2000, Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy, Diabetes, 49, 1325, 10.2337/diabetes.49.8.1325 · DOI · Paper page
  20. Kassem, 2010, Large islets, beta-cell proliferation, and a glucokinase mutation, N. Engl. J. Med., 362, 1348, 10.1056/NEJMc0909845 · DOI
  21. Kiyosue, 2013, Dose-ranging study with the glucokinase activator AZD1656 as monotherapy in Japanese patients with type 2 diabetes mellitus, Diabetes Obes. Metab., 15, 923, 10.1111/dom.12100 · DOI
  22. Las, 2010, The role of autophagy in β-cell lipotoxicity and type 2 diabetes, Diabetes Obes. Metab., 12, 15, 10.1111/j.1463-1326.2010.01268.x · DOI
  23. Maedler, 2004, Diabetes, 53, 1706, 10.2337/diabetes.53.7.1706 · DOI
  24. Marino, 2000, Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum, Genes Dev., 14, 994, 10.1101/gad.14.8.994 · DOI · Paper page
  25. Meacham, 2009, Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study, Arch. Intern. Med., 169, 1381, 10.1001/archinternmed.2009.209 · DOI · Paper page
  26. Meininger, 2011, Effects of MK-0941, a novel glucokinase activator, on glycemic control in insulin-treated patients with type 2 diabetes, Diabetes Care, 34, 2560, 10.2337/dc11-1200 · DOI · Paper page
  27. Miki, 2001, Roles of ATP-sensitive K+ channels in cell survival and differentiation in the endocrine pancreas, Diabetes, 50, S48, 10.2337/diabetes.50.2007.S48 · DOI
  28. Miller, 2000, Neuronal life and death: an essential role for the p53 family, Cell Death Differ., 7, 880, 10.1038/sj.cdd.4400736 · DOI · Paper page
  29. Moore, 2008, Hyperinsulinemia and insulin resistance in Wrn null mice fed a diabetogenic diet, Mech. Ageing Dev., 129, 201, 10.1016/j.mad.2007.12.009 · DOI
  30. Murtaugh, 2003, Notch signaling controls multiple steps of pancreatic differentiation, Proc. Natl. Acad. Sci. USA, 100, 14920, 10.1073/pnas.2436557100 · DOI · Paper page
  31. Nakamura, 2009, Impact of small-molecule glucokinase activator on glucose metabolism and beta-cell mass, Endocrinology, 150, 1147, 10.1210/en.2008-1183 · DOI
  32. Nakamura, 2012, Control of beta cell function and proliferation in mice stimulated by small-molecule glucokinase activator under various conditions, Diabetologia, 55, 1745, 10.1007/s00125-012-2521-5 · DOI
  33. Neema, 2005, DNA damage and nonhomologous end joining in excitotoxicity: neuroprotective role of DNA-PKcs in kainic acid-induced seizures, Hippocampus, 15, 1057, 10.1002/hipo.20123 · DOI
  34. Nito, 2011, FK506 ameliorates oxidative damage and protects rat brain following transient focal cerebral ischemia, Neurol. Res., 33, 881, 10.1179/1743132811Y.0000000019 · doi:10.1179/1743132811y.0000000019
  35. Porat, 2011, Control of pancreatic β cell regeneration by glucose metabolism, Cell Metab., 13, 440, 10.1016/j.cmet.2011.02.012 · DOI · Paper page
  36. Rahier, 2011, Morphologic analysis of focal and diffuse forms of congenital hyperinsulinism, Semin. Pediatr. Surg., 20, 3, 10.1053/j.sempedsurg.2010.10.010 · DOI
  37. Ritzel, 2010, Beta-cell selective K(ATP)-channel activation protects beta-cells and human islets from human islet amyloid polypeptide induced toxicity, Regul. Pept., 165, 158, 10.1016/j.regpep.2010.06.009 · DOI
  38. Sakhi, 1994, p53 induction is associated with neuronal damage in the central nervous system, Proc. Natl. Acad. Sci. USA, 91, 7525, 10.1073/pnas.91.16.7525 · DOI · Paper page
  39. Sakuraba, 2002, Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients, Diabetologia, 45, 85, 10.1007/s125-002-8248-z · DOI · Paper page
  40. Sayed, 2009, Extremes of clinical and enzymatic phenotypes in children with hyperinsulinism caused by glucokinase activating mutations, Diabetes, 58, 1419, 10.2337/db08-1792 · DOI
  41. Schultz, 2000, p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks, J. Cell Biol., 151, 1381, 10.1083/jcb.151.7.1381 · DOI · Paper page
  42. Shimoda, 2011, The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes, Diabetologia, 54, 1098, 10.1007/s00125-011-2069-9 · DOI · Paper page
  43. Shirakawa, 2013, Glucokinase activation ameliorates ER stress-induced apoptosis in pancreatic β-cells, Diabetes, 62, 3448, 10.2337/db13-0052 · DOI
  44. Snider, 2013, Genotype and phenotype correlations in 417 children with congenital hyperinsulinism, J. Clin. Endocrinol. Metab., 98, E355, 10.1210/jc.2012-2169 · DOI · Paper page
  45. Srinivas, 2001, Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus, BMC Dev. Biol., 1, 4, 10.1186/1471-213X-1-4 · DOI · Paper page
  46. Suberbielle, 2013, Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-β, Nat. Neurosci., 16, 613, 10.1038/nn.3356 · DOI · Paper page
  47. Wang, 2011, Nifedipine Protects INS-1 β-Cell from High Glucose-Induced ER Stress and Apoptosis, Int. J. Mol. Sci., 12, 7569, 10.3390/ijms12117569 · DOI
  48. Wicksteed, 2010, Conditional gene targeting in mouse pancreatic ß-Cells: analysis of ectopic Cre transgene expression in the brain, Diabetes, 59, 3090, 10.2337/db10-0624 · DOI · Paper page
  49. Wilding, 2013, Dose-ranging study with the glucokinase activator AZD1656 in patients with type 2 diabetes mellitus on metformin, Diabetes Obes. Metab., 15, 750, 10.1111/dom.12088 · DOI
  50. Yusta, 2006, GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress, Cell Metab., 4, 391, 10.1016/j.cmet.2006.10.001 · DOI · Paper page

Cited by

See all 141

Metadata

Authors
Tornovsky-Babeay, S., Dadon, D., Ziv, O., Tzipilevich, E., Kadosh, T., Schyr-Ben Haroush, R., Hija, A., Stolovich-Rain, M., Furth-Lavi, J., Granot, Z., Porat, S., Philipson, L. H., Herold, K. C., Bhatti, T. R., Stanley, C., Ashcroft, F. M., In’t Veld, P., Saada, A., Magnuson, M. A., Glaser, B., & Dor, Y.
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2014-01
Volume
19
Issue
1
Pages
109-121
ISSN
1550-4131
DOI
10.1016/j.cmet.2013.11.007
Cited by
141
References
11
Language
en
Licence
Funders
  • United States Agency for International Development
  • Israeli Centers for Research Excellence
  • Juvenile Diabetes Research Foundation United States of America
  • European Research Council
  • Israel Science Foundation (41.11)
  • Novo Nordisk
  • Seventh Framework Programme (241883)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Type 2 Diabetes and Congenital Hyperinsulinism Cause DNA Double-Strand Breaks and p53 Activity in β Cells. https://app.cochat.ai/papers/10.1016/j.cmet.2013.11.007
The paper
Tornovsky-Babeay, S., Dadon, D., Ziv, O., Tzipilevich, E., Kadosh, T., Schyr-Ben Haroush, R., Hija, A., Stolovich-Rain, M., Furth-Lavi, J., Granot, Z., Porat, S., Philipson, L. H., Herold, K. C., Bhatti, T. R., Stanley, C., Ashcroft, F. M., In’t Veld, P., Saada, A., Magnuson, M. A., . . . Dor, Y. (2014). Type 2 Diabetes and Congenital Hyperinsulinism Cause DNA Double-Strand Breaks and p53 Activity in β Cells. Cell Metabolism. https://doi.org/10.1016/j.cmet.2013.11.007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.